Flow Cytometry News and Research RSS Feed - Flow Cytometry News and Research

Flow cytometry is a technique for counting and examining microscopic particles suspended in a stream of fluid. It allows simultaneous multiparametric analysis of the physical and/or chemical characteristics of single cells flowing through an optical and/or electronic detection apparatus.

Research report on flow cytometry market

According to the new market research report "Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the world (RoW). [More]
Stowers team reports genome-wide analysis of genes that drive cell division in multicellular organism

Stowers team reports genome-wide analysis of genes that drive cell division in multicellular organism

​In textbooks, the grand-finale of cell division is the tug-of-war fought inside dividing cells as duplicated pairs of chromosomes get dragged in opposite directions into daughter cells. [More]

Research report on global flow cytometry market

Dublin - Research and Markets has announced the addition of the "Flow Cytometry Market (Products, Application, Technology, and Users) - Forecast to 2020" report to their offering. [More]
Beckman Coulter Life Sciences’ Avanti centrifuges combine high performance and application versatility

Beckman Coulter Life Sciences’ Avanti centrifuges combine high performance and application versatility

Combining high performance and application versatility, Avanti JXN-26 centrifuges from Beckman Coulter Life Sciences offer laboratories an intuitive interface and advanced data management features that expand functionality and flexibility to free user time in research and bioproduction. The instruments can be run from an Apple iOS or Android device using MobileFuge, the only mobile application available to run and manage laboratory centrifuges. [More]
New research may open door to novel therapies for treating immune disorders

New research may open door to novel therapies for treating immune disorders

A new research discovery published in the April 2014 issue of the Journal of Leukocyte Biology may open the door to new therapies that help treat immune disorders or curb runaway inflammation. Specifically, scientists have discovered a molecule that can induce cell death (apoptosis) in a key type of immune cell (dendritic cells). [More]

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

North Shore InnoVentures, one of New England's leading technology incubators and business accelerators, announced today that it has received a capital grant of $1.65 million from the Massachusetts Life Sciences Center. [More]
New technology uses nano-flares to catch metastatic breast cancer cells early on

New technology uses nano-flares to catch metastatic breast cancer cells early on

When cancer spreads from one part of the body to another, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses "nano-flares" has the potential to catch these lurking, mobilized tumor cells early on. [More]
Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore, the Life Science division of Merck, today announced a clinical research, licensing and joint development agreement with Sysmex Corporation of Japan. [More]

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Quintiles last night was named the "Best CRO in Asia" at the 2014 BioPharma Asia Industry Awards dinner, the third time in the event's four-year history that Quintiles has received the honor. [More]
Study shows how immune system reconstitutes itself following immune-depleting therapy

Study shows how immune system reconstitutes itself following immune-depleting therapy

A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. [More]

Fluidigm acquires DVS Sciences

Fluidigm Corp. today announced it has completed its acquisition of DVS Sciences, Inc. With the closing of the acquisition, Fluidigm adds a high-parameter single-cell protein analysis platform to its industry-leading single-cell genomics platforms to create a comprehensive portfolio of advanced technologies serving the rapidly growing single-cell genomics and proteomics markets. [More]

NeoGenomics validates and launches series of NeoTYPE cancer profiling tests

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has validated and launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer. Each of these tests is designed to investigate the most common and actionable genomic abnormalities reported for that particular tumor. [More]
ACM Global acquires Phoenix PCS to expand operation in the Asia Pacific region

ACM Global acquires Phoenix PCS to expand operation in the Asia Pacific region

ACM Global Central Laboratory, a diagnostic central laboratory specializing in delivering high quality testing services which optimize clinical trial outcomes, today announced it has acquired Phoenix Pharma Central Services Pte. Ltd, a premier central laboratory services provider for Asia Pacific clinical trials, with laboratory facilities in Singapore and Shanghai, China. The acquisition enables ACM Global to deliver increased operational and financial efficiencies to clients conducting clinical studies in the Asia Pacific region. Terms of the transaction were not disclosed. [More]
Aptamer kits for cell isolation and flow cytometry introduced by AMSBIO

Aptamer kits for cell isolation and flow cytometry introduced by AMSBIO

AMSBIO has announced the introduction of new aptamer kits for cell isolation and flow cytometry. Aptamers are oligonucleotides or peptides that bind to a specific target molecule. Aptamers are useful in biotechnological and therapeutic applications as they offer molecular recognition properties that rival that of the commonly used biomolecule, antibodies. [More]
NeoGenomics launches new test for detection of mutations in CALR gene

NeoGenomics launches new test for detection of mutations in CALR gene

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched a new test for the detection of mutations in the calreticulin (CALR) gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms (MPN) for the first time at the annual meeting of the American Society of Hematology last month. [More]
Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics, Inc. today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA™) at the 55TH Annual meeting of the American Society of Hematology (ASH) held in New Orleans, Dec 7 - 10, 2013. [More]
People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

People living with chronic fatigue are set to benefit with the opening next week (Dec 2), of the National Centre for Neuroimmunology and Emerging Diseases at Griffith University. [More]
microRNAs may serve as therapeutic targets and predictors of metastasis

microRNAs may serve as therapeutic targets and predictors of metastasis

A class of molecules called microRNAs may offer cancer patients two ways to combat their disease. [More]
Malvern Instruments Acquires Nanosight

Malvern Instruments Acquires Nanosight

... [More]

Second edition of Antibodies: An essential resource for molecular biology, immunology, and cell culture lab

The now classic lab manual Antibodies, by Harlow and Lane, has been revised, extended, and updated by Edward Greenfield of the Dana-Farber Cancer Center, with contributions from other leaders in the field. [More]